Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nontraditional microbial bioactive metabolites.

V Bĕhal1

  • 1Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czechia. behal@biomed.cas.cz

Folia Microbiologica
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternative sources of biologically active substances.

Folia microbiologica·2004
Same author

Bioactive products from Streptomyces.

Advances in applied microbiology·2003
Same author

Hybrid antibiotics.

Folia microbiologica·2003
Same author

Antibiotics.

Biotechnology annual review·2002
Same author

Conversion of glutamate to glutamine by permeabilized Corynebacterium glutamicum.

Folia microbiologica·2000
Same author

Expression of the Csp protein family upon cold shock and production of tetracycline in Streptomyces aureofaciens.

Biochemical and biophysical research communications·1999
Same journal

Molecular epidemiology and clinical course of PVL-positive MRSA CC398 infections.

Folia microbiologica·2026
Same journal

Proline treatment improves salinity tolerance in the green microalga Dunaliella sp. by altering carbon partitioning and inducing metabolites accumulation.

Folia microbiologica·2026
Same journal

Czechoslovak/Prague School of Immunology.

Folia microbiologica·2026
Same journal

Anti-Candida albicans and anti-virulence activities of vaginal Lactobacillus strains from asymptomatic women: phenotypic characterization and prediction of antimicrobial peptide gene clusters.

Folia microbiologica·2026
Same journal

The integrative role of the microbiome in systemic immuno-inflammatory aberrations.

Folia microbiologica·2026
Same journal

Gnotobiology: from 19th-century global foundations to 21st-century omics - six decades of Czech contribution to microbiome research.

Folia microbiologica·2026
See all related articles

Microorganisms create diverse secondary metabolites with significant biological activities, including antimicrobial and antifungal properties. Ongoing research continues to uncover novel microbial compounds with potential therapeutic applications.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Microorganisms synthesize low-molar-mass secondary metabolites with varied biological activities.
  • These compounds include antimicrobials, antifungals, alkaloids, and toxins, utilized in medicine and other applications.
  • Diverse microbial groups like streptomycetes, fungi, and bacilli, as well as extremophiles, are sources of these valuable substances.

Purpose of the Study:

  • To highlight the significance of microbial secondary metabolites.
  • To underscore the potential of discovering new bioactive compounds from microorganisms.
  • To emphasize the broad range of applications for these natural products.

Main Methods:

  • Literature review of microbial secondary metabolite production and applications.

Related Experiment Videos

  • Analysis of known bioactive compounds from various microbial sources.
  • Exploration of potential discovery avenues, including extremophilic microorganisms.

    • Main Results:

    • Thousands of microbial products have been identified to date.
    • These metabolites exhibit a wide spectrum of biological activities and structural diversity.
    • Microorganisms, particularly those in extreme environments, are a promising source for novel compounds.

    Conclusions:

    • Microbial secondary metabolites represent a rich resource for drug discovery and development.
    • Continued exploration of microbial diversity, especially extremophiles, is crucial for identifying new therapeutic agents.
    • The potential for discovering novel, useful compounds remains substantial.